Dr Gabriel Rebollón G

President, Fundación Sangre Panamá
  • Panama
Jim Swanson

Enterprise CIO, Johnson & Johnson

Jim Swanson is a global business and technology leader and currently Chief Information Officer of Johnson & Johnson, the world’s premier healthcare company. Based at the company headquarters in New Jersey, Jim is responsible for amplifying Johnson & Johnson’s business impact and shaping its direction through the strategic use of technology. Jim joined Johnson & Johnson from Bayer Crop Science, a $20 billion division of Bayer, where he served as a member of the Executive Leadership Team and as CIO and Head of Digital Transformation. In this role, he inspired teams across the world to use digital innovation and data science to transform and deliver world-class products and services sustainably. Jim and the Information Technology organizations he has led have received industry accolades for their contributions in leadership, application of technology to deliver substantial business value, best places to work in IT, and support of STEM for emerging talent. Previously, Jim served as CIO at Monsanto for five years before the company was acquired by Bayer. In addition, he had nine years of experience working as Vice President and CIO for Johnson & Johnson Pharmaceutical Research & Development, where he advanced technology throughout the company’s R&D organization.
Marion Birnstill

Global Community Impact EMEA, Johnson & Johnson

Marion works for the Johnson & Johnson Foundation and is collaborating on the delivery of the Johnson & Johnson Global Community Impact strategy in EMEA and for realizing its vision of supporting and championing the people on the front lines of delivering care. Marion is a seasoned global health and partnering professional with close to 12 years’ experience spanning a career working for leading organisations across the private, public and non-profit sectors. Throughout the years Marion built a career co-creating, facilitating and managing partnerships across big and small organisations and discovered that social change and improvement of health is not enough. Privileged to work with some of the leading health innovators, system’s thinkers and entrepreneurs, she has been challenging the status quo by advocating for new ways of partnering with the belief that collective action and impact approaches are needed to drive transformation and systemic change. She has also been exploring how to best invest in resilience at individuals, communities and health systems level to shift from curing bad health to sustaining good health. Marion obtained a Degree in Literature and Philosophy in France and Germany and graduated with a Master’s Degree in International Business in London where she specialized in Corporate Social Responsibility in the pharmaceutical industry. Marion is a native French speaker and is fluent in German and English. She is passionate about swimming against the tide, bringing up her son as responsible global citizen, and finding inner peace thanks to yoga!
David Nabarro

Special Envoy of the Director-General on COVID-19, World Health Organization

David Nabarro is Co-Director of the Institute for Global Health Innovation at Imperial College London and Strategic Director of 4SD Systems Leadership Mentoring, Switzerland. He served for 17 years within the United Nations (UN) system, including roles in the World Health Organization 2004 – 05 and in the office of the UN Secretary-General (including coordinating Influenza Pandemic Preparedness 2005 – 10, the High Level Task Force on Food Security 2008 - 14, the Scale Up Nutrition Movement 2010 – 14, UN responses to Ebola Virus Disease in West Africa 2014 – 15, and action on the 2030 Agenda for Sustainable Development and Climate Change 2016 – 17).
Michelle McIsaac

Health Economist, World Health Organization

Martin Wenzl

Health Policy Analyst, OECD

Daniel Gómez

Vice President, Private Competitiveness Council

Vicepresident at the Consejo Privado de Competitividad and Adjunct professor of public policy at Universidad de los Andes. Daniel Gómez was Deputy Director at the National Planning Department in Colombia. Previously he was a Senior Economist in the Finance, Competitiveness, and Innovation (FCI) LAC World Bank team. Based in Buenos Aires, he was the focal point for FCI work in the Southern Cone (Argentina, Paraguay, and Uruguay). Daniel has experience in competitiveness; productive development policy; science, technology, and innovation policies; trade policy; and competition policy. He holds a Ph.D. in Business Economics with specializations in international trade and industrial organization from the University of Chicago, an MBA from the Booth School of Business, and a degree in Economics and a Masters in Banking and Finance at HEC University of Lausanne. Before joining the World Bank, he was Head of Competitiveness Research at the World Economic Forum (WEF), where he led the production of the Global Competitiveness Report. He designed and led country engagement strategies including competitiveness labs and workshops in Mexico, Peru, Colombia, Brazil, Argentina, El Salvador, and Guatemala. He also led research on technological diffusion and productive transformation. Prior to the WEF, Daniel was advisor to the Minister of Trade, Industry, and Tourism of Colombia, where he led policy work on competitiveness and productive development policy; a researcher with Fedesarrollo, the main public policy think tank in Colombia; and an adjunct professor of economics at Universidad de los Andes and Universidad Javeriana in Bogotá. Before completing his Ph.D., he was an antitrust consultant with NERA and LECG’s European Competition Policy Practices.
Onur Turk

Founder, Haros

Yvonne Mburu

Founder and CEO, Nexakili

Medical Science, Health, Diasporas

Professor and Health scientist, Endepusresearch Inc and University AixMarseille

Beatrice TARDIEU

Senior Director-EMEA Public Affairs and Health Policy Center, Johnson & Johnson

Dr in Pharmacy, ESSEC MBA, 32 years in Healthcare Business, Communications and Public Affairs
Coen H. van Gool

Researcher, National Institute for Public Health and the Environment (RIVM)


Senior Director- EMEA Communication & Public Affairs-Health Policy Center at Janssen EMEA, Janssen-Cilag

Julie Gerberding

Executive Vice President Strategic Communications, Global Public Policy, and Population Health, MSD

Hiroto Ito

Director, National Institute of Mental Health, National Center of Neurology and Psychiatry

Allison Colbert

OECD Health Policy Division, OECD